Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases

Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases

Abstract Background Immune checkpoint inhibitors (ICPIs) are being investigated in clinical trials for patients with glioblastoma. While these therapies hold great promise, management of the patients receiving such treatment can be complicated due to the challenges in recognizing immune-related adve...

Full description

Bibliographic Details
Main Authors: Surabhi Ranjan, Martha Quezado, Nancy Garren, Lisa Boris, Christine Siegel, Osorio Lopes Abath Neto, Brett J. Theeler, Deric M. Park, Edjah Nduom, Kareem A. Zaghloul, Mark R. Gilbert, Jing Wu
Format: Article
Language:English
Published: BMC 2018-03-01
Series:BMC Cancer
Subjects:
CTLA-4
Immune checkpoint inhibitors
Immunotherapy
Ipilimumab
iRANO
PD-1
Online Access:http://link.springer.com/article/10.1186/s12885-018-4131-1

Internet

http://link.springer.com/article/10.1186/s12885-018-4131-1

Similar Items